Institute of Statistical Research and Training
Research Profile
| Degree Name | Group/Major Subject | Board/Institute | Country | Passing Year |
|---|---|---|---|---|
| Ph.D. | Statistics | Queen Mary Deltin 7 Aviator গেম টাকা ইনকাম of London | United Kingdom | 2015 |
| Masters | Applied Statistics | Deltin 7 Aviator গেম টাকা ইনকাম of Deltin 7 | Bangladesh | 2005 |
| Bachelor | Applied Statistics | Deltin 7 Aviator গেম টাকা ইনকাম of Deltin 7 | Bangladesh | 2003 |
| Title | Organization | Location | From Date | To Date |
|---|---|---|---|---|
| Professor | Deltin 7 Aviator গেম টাকা ইনকাম of Deltin 7 | Bangladesh | 15, Feb 2023 | Currently Working |
| Associate Professor | Deltin 7 Aviator গেম টাকা ইনকাম of Deltin 7 | Bangladesh | 15, Jun 2017 | 14-02-2023 |
| Assistant Professor | Deltin 7 Aviator গেম টাকা ইনকাম of Deltin 7 | Bangladesh | 25, Aug 2010 | 14-06-2017 |
| Lecturer | Deltin 7 Aviator গেম টাকা ইনকাম of Deltin 7 | Bangladesh | 27, Jan 2007 | 24-08-2010 |
| Subject | Description | Research Interest (Goal, Target Indicator) |
|---|---|---|
| Statistical computing | ||
| Clinical trials | ||
| Optimal design | ||
| Adaptive design |
| Level of Study | Title | Supervisor | Co-Supervisor(s) | Name of Student(s) | Area of Research | Current Completion |
|---|---|---|---|---|---|---|
| Masters | Patient-specific dose finding in seamless phase I/II clinical trials | M. Iftakhar Alam | Shantonu Islam | Clinical Trials |
2019 | |
| Masters | A two-stage adaptive design for phase II clinical trials | M. Iftakhar Alam | Rezoanoor Rahman | Biostatistics | 2019 | |
| Masters | Patient-specific dose finding in phase I clinical trials | M. Iftakhar Alam | Monirruzzaman Moni | Biostatistics | 2018 | |
| Masters | Early stopping in seamless phase I/II clinical trials | M. Iftakhar Alam | Noor Muhammad Khan | Biostatistics | 2018 | |
| Masters | D-optimal designs for dose finding in phase I clinical trials | M. Iftakhar Alam | Hasan Mahmud | Biostatistics | 2017 | |
| Masters | Construction of windows for pharmacokinetic sampling | M. Iftakhar Alam | Nigar Sultana | Biostatistics | 2017 | |
| Masters | Assessing the inter-patient variability in the area under the concentration curve | M. Iftakhar Alam | Syeda Asma Akter | Biostatistics | 2016 |
| Subject | Project Name | Source of Fund | From Date | To Date | Collaboration |
|---|---|---|---|---|---|
| No project/research work is found | |||||
| SL | Invited Talk |
|---|---|
| No invited talk is found | |
| SL | Collaboration & Membership Name | Type | Membership Year | Expire Year |
|---|---|---|---|---|
| 1 | International Society for Clinical Biostatistics, Denmark | Member | 2014- Till today | |
| 2 | International Statistical Institute, The Hague, Netherlands | Member | 2017-Till today |
| Journal Article | |
|---|---|
| 1 |
M. Iftakhar Alam, Barbara Bogacka and Steve Coad : A constrained optimum adaptive design for dose finding in early phase clinical trials,
Journal of Biopharmaceuticals , 2024
.
|
| 2 |
M. Iftakhar Alam, Nigar Sultana and Humaira Sultana : Prevalence and determinants of discrimination or harassment of women: Analysis of cross-sectional data from Bangladesh,
PLOS ONE , vol.19 , no.4 , pp.e0302059. , 2024
.
|
| 3 |
Maisha Maliha Rahman, M. Iftakhar Alam and Mohaimen Mansur : Functional difficulty among young children in Bangladesh: An analysis of nationally representative data,
PLOS ONE , vol.19 , no.3 , pp.e0300403 , 2024
.
|
| 4 |
M. Iftakhar Alam and Nigar Sultana : Skilled birth attendants and caesarean sections: a case in Bangladesh,
Journal of Public Health , vol.33 , pp.435-443 , 2023
.
|
| 5 |
M. Iftakhar Alam and Shantanu Islam Shanto : Patient-specific dose finding in seamless phase I/II clinical trials,
Sequential Analysis , vol.41 , no.3 , pp.367-386 , 2022
.
|
| 6 |
M. Iftakhar Alam, Mohaimen Mansur and Prianka Barman : Early childhood development in Bangladesh and its socio-demographic determinants of importance,
Early Child Development and Care , vol.192 , no.12 , pp.1901-1920 , 2022
.
|
| 7 |
Hasan Mahmud Sujan and M. Iftakhar Alam : D-optimal designs for dose finding in phase I clinical trials,
Journal of Statistical Research , vol.55 , no.2 , pp.313-334 , 2022
.
|
| 8 |
Rezoanoor Rahman and M. Iftakhar Alam : Stopping for efficacy in single-arm phase II clinical trials,
Journal of Applied Statistics , vol.49 , no.10 , pp.2447-2466 , 2022
.
|
| 9 |
M. Iftakhar Alam and Nigar Sultana : Attitudes of Women Toward Domestic Violence: What Matters the Most?,
Violence and Gender , vol.9 , no.2 , pp.87-95 , 2022
.
|
| 10 |
Rownak Jahan Tamanna, M. Iftakhar Alam, Ahmed Hossain and Hasinur Rahman Khan : On sample size calculation in testing treatment efficacy in clinical trials,
Biometrical Letters , vol.58 , no.2 , pp.133-147 , 2021
.
|
| 11 |
M. Iftakhar Alam and Nigar Sultana : Construction of windows for pharmacokinetic sampling,
Austrian Journal of Statistics , vol.50 Austrian Statistical Society , pp.23-37 , 2021
.
|
| 12 |
Noor M. Khan and M. I. Alam : Early stopping in seamless phase I/II clinical trials,
Pharmaceutical Statistics , vol.20 , no.2 Wiley , pp.390-412 , 2020
.
|
| 13 |
Alam, M. I, Coad, D.S. and Bogacka, B. : Combined criteria for dose optimisation in early phase clinical trials,
Statistics in Medicine , vol.38 , no.21 Wiley , pp.4172-4188 , 2019
.
|
| 14 |
Alam, M.I. and Sultana, Jafrin : Isotonic design for phase I clinical trials: can we improve further?,
Austrian Journal of Statistics , vol.48 Austrian Statistical Society , pp.34-44 , 2019
.
|
| 15 |
M. I. Alam : Assessing the inter-patient variability in the area under the concentration curve,
Journal of Statistical Research , vol.53 , no.1 , pp.27-44 , 2019
.
|
| 16 |
Moni, M.M. and Alam, M.I. : Patient-specific dose finding in phase I clinical trials,
Journal of Applied Statistics , vol.45 , no.14 Taylor and Francis , pp.2607-2618 , 2018
.
|
| 17 |
Alam, M.I. and Mansur, Mohaimen : A dynamic stopping rule for phase I clinical trials,
Biometrical Letters , vol.55 , no.1 Polish Biometric Society , pp.17-30 , 2018
.
|
| 18 |
Alam, M.I. and Hossain, M.I. : On performance of the 3+3 design and its modified versions for dose finding in phase I clinical trials,
Journal of Data Science , vol.15 , no.1 , pp.115-128 , 2017
.
|
| 19 |
Alam, M.I., Bogacka, B. and Coad, D.S. : Pharmacokinetically guided optimum adaptive dose selection in early phase clinical trials,
Computational Statistics and Data Analysis , vol.117 , no.2017 Elsevier , pp.183-202 , 2017
.
|
| 20 |
Alam, M.I. : A comparison between the continual reassessment method and D-optimum design for dose finding in phase I clinical trials,
Biometrical Letters , vol.53 , no.2 Polish Biometric Society , pp.69-82 , 2016
.
|
| 21 |
M. Iftakhar Alam, Mohaimen Mansur and Prianka Barman : Early childhood development in Bangladesh and its socio-demographic determinants of importance,
Early Child Development and Care Taylor and Francis , pp.1-20 , 2021
.
|
| 22 |
Hasan Mahmud Sujan and M. Iftakhar Alam : D-optimal designs for dose finding in phase I clinical trials,
Journal of Statistical Research , vol.55 , no.2 , pp.313-334 , 2022
.
|
| Award Type | Title | Year | Country | Description |
|---|---|---|---|---|
| International | Conference Award for Scientists | 2016 | United Kingdom | Received from the International Society for Clinical Biostatistics (ISCB). I was one of the three early-career researchers from the developing nations to receive this award. |
| International | Student Conference Award | 2013 | Germany | Received from the International Society for Clinical Biostatistics (ISCB). I was one of the three research students worldwide to receive this award. |
| National | Fazlul Huq Hall Provost Award | 2004 | Bangladesh | Received for securing the first position in the B.Sc. (Honours) final examination. |